VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
16 hedge funds and large institutions have $7.67M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$336K | |
| 2 | +$166K | |
| 3 | +$129K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$86K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$52K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$399K | |
| 3 | -$123K | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$90K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$6.01K |